Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S2 from A Phase II Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2
  1. Home
  2. Publications
  3. Supplementary Figure S2 from A Phase II Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2

Supplementary Figure S2 from A Phase II Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2

Authors:
  • BHBrandon M. Huffman
    Brandon M. Huffman
  • MDMiklos Diossy
    Miklos Diossy
  • MYMatthew B. Yurgelun
    Matthew B. Yurgelun
  • NHNora Horick
    Nora Horick
  • YLYvonne Y. Li
    Yvonne Y. Li
  • JCJett Crowdis
    Jett Crowdis
  • HNHuy Nguyen
    Huy Nguyen
  • KPKalindi Parmar
    Kalindi Parmar
  • BKBose S. Kochupurakkal
    Bose S. Kochupurakkal
  • LVLeonard Vonk
    Leonard Vonk
  • HLHelen Lam
    Helen Lam
  • KRKaitlyn Ramsey
    Kaitlyn Ramsey

Open Access
Publisher website
Google Scholar
  • 17 June 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.32711195
Abstract
Supplementary Figure S2: Kaplan-Meier estimates of overall survival (OS) in patients treated with niraparib across the entire trial population
Keywords
  • SUPPLEMENTARY FIGURE
  • ADVANCED PANCREATIC
  • PANCREATIC CANCER
  • CANCER HARBORING
  • HARBORING PATHOGENIC
  • PATHOGENIC VARIANTS
  • TRIAL POPULATION
  • KAPLAN-MEIER ESTIMATES
  • PATIENTS TREATED
  • ENTIRE TRIAL
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.